Company intelligence / Profile preview

City of Santa Cruz

Dallas, Texas, United Statescityofsantacruz.com ↗

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Santa Cruz Biotechnology is one of the world’s largest suppliers of antibodies and related reagents for biomedical research. It offers monoclonal antibodies, gene silencers (siRNA/shRNA), CRISPR/Cas9 products, biochemicals, and labware to academic institutions and industry worldwide. The company has been cited in over 360,000 scientific publications[1][2]. It does not develop drugs or clinical candidates but supports preclinical discovery through its reagent portfolio.

Modalities: Monoclonal antibodySmall interfering RNAShort hairpin RNA therapyCRISPR-based therapyBiologicSmall molecule
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on City of Santa Cruz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on City of Santa Cruz.

Explore the full profile